EP Patent

EP2687235A3 — Methods for production and use of substance-loaded erythrocytes (S-LES) for observation and treatment of microvascular hemodynamics

Assigned to Novadaq Technologies ULC · Expires 2014-11-05 · 12y expired

What this patent protects

Disclosed herein are methods, kits, and compositions for medical imaging relating to fluorescent dyes entrapped in erythrocytes. Also disclosed therein are methods, and compositions further comprising erythrocytes entrapping at least one therapeutically active agent.

USPTO Abstract

Disclosed herein are methods, kits, and compositions for medical imaging relating to fluorescent dyes entrapped in erythrocytes. Also disclosed therein are methods, and compositions further comprising erythrocytes entrapping at least one therapeutically active agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP2687235A3
Jurisdiction
EP
Classification
Expires
2014-11-05
Drug substance claim
No
Drug product claim
No
Assignee
Novadaq Technologies ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.